Purpose: Ulcerative colitis has classically been described as a continuous mucosal inflammation originating in the distal colon and spreading proximally. Isolated peri-appendiceal lesions (cecal patch) have been recognized in the patients with ulcerative proctitis for over 30 years, but their clinical significance remains unclear. The purpose of this study was to evaluate the risk of progression to pancolitis in patients presenting with a skipped peri-appendiceal lesion on ileocolonoscopy. Methods: In this retrospective chart review study we have searched the endoscopic database at the University of Minnesota and the Minneapolis VA Medical Center from 1997 to 2007 for patients undergoing ileocolonoscopy for either the initial diagnosis or surveillance of ulcerative colitis. Those patients with a biopsy-proven, isolated peri-appendiceal lesion as well as histologically confirmed left sided colitis or proctitis were enrolled in the study. Controls were defined as patients with left-sided ulcerative colitis without endoscopic evidence of peri-appendiceal inflammation. Progression was defined as endoscopic proximal extension to at least the transverse colon. Secondary markers for disease progression were utilization of a TNF inhibitor therapy or colectomy. A secondary analysis of other risk factors for proximal extension/progression of colitis was also performed. Results: We reviewed 158 patients with ulcerative colitis: 19% with proctitis, 34% left-sided colitis, 36% pancolitis. Disease extent was unknown in 11% of patients. We identified 6 patients with peri-appendiceal lesions yielding a prevalence of 3.8 percent. There was no statistically significant difference in inflammatory marker levels, initial therapy required, or the average Mayo endoscopic severity score at the time of diagnosis for cases and controls. In the group with a peri-appendiceal lesion, 25% of the patients progressed to pancolitis vs. 38 % of the controls (p = 0.60). Utilization of TNF inhibitors trended toward being greater in the cecal patch group (50% vs. 19%, p = 0.06) but colectomy rates did not differ (12% vs. 17%, p = 0.72). Of the 89 patients with left-sided colitis or proctitis, 58 had adequate data to include in the analysis for risk for progression. Among those with proximal extension of colitis, this progression was not predicted by inflammatory markers, age, gender, initial Mayo UC score or IBD therapy utilization. Conclusion: Isolated cecal patches are rare. Patients with isolated peri-appendiceal lesions are at no greater risk for colectomy or utilization of TNF inhibitors. No other predictors of disease progression were identified in this cohort.